Cargando…

Toward Mass Drug Administration Stopping Criteria for Schistosoma mansoni Control Programs

Detalles Bibliográficos
Autor principal:	Secor, W. Evan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402939/ https://www.ncbi.nlm.nih.gov/pubmed/30719966 http://dx.doi.org/10.4269/ajtmh.19-0011

Ejemplares similares

Evaluation of the Point-of-Care Circulating Cathodic Antigen Assay for Monitoring Mass Drug Administration in a Schistosoma mansoni Control Program in Western Kenya
por: Straily, Anne, et al.
Publicado: (2022)

Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa
por: King, Charles H., et al.
Publicado: (2020)

Schistosoma mansoni Mass Drug Administration Regimens and Their Effect on Morbidity among Schoolchildren over a 5-Year Period—Kenya, 2010–2015
por: Sircar, Anita D., et al.
Publicado: (2018)

Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial Schistosoma mansoni Infection Prevalence: A Cluster Randomized Trial
por: Secor, W. Evan, et al.
Publicado: (2020)

Cluster randomized trial comparing school-based mass drug administration schedules in areas of western Kenya with moderate initial prevalence of Schistosoma mansoni infections
por: Karanja, Diana M. S., et al.
Publicado: (2017)

Early lessons from schistosomiasis mass drug administration programs
por: Secor, W. Evan
Publicado: (2015)

Mass drug administration significantly reduces infection of Schistosoma mansoni and hookworm in school children in the national control program in Sierra Leone
por: Hodges, Mary H, et al.
Publicado: (2012)

Schistosoma mansoni infection after three years of mass drug administration in Sierra Leone
por: Sesay, Santigie, et al.
Publicado: (2014)

SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection
por: King, Charles H., et al.
Publicado: (2020)

Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration
por: Crellen, Thomas, et al.
Publicado: (2016)

Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
por: Kura, Klodeta, et al.
Publicado: (2019)

Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western Kenya
por: Onkanga, Isaac O., et al.
Publicado: (2016)

Idiotypes Expressed Early in Experimental Schistosoma mansoni Infections Predict Clinical Outcomes of Chronic Disease
por: Montesano, M. Angela, et al.
Publicado: (2002)

Whole-genome sequencing of Schistosoma mansoni reveals extensive diversity with limited selection despite mass drug administration
por: Berger, Duncan J., et al.
Publicado: (2021)

Use of Geospatial Modeling to Predict Schistosoma mansoni Prevalence in Nyanza Province, Kenya
por: Woodhall, Dana M., et al.
Publicado: (2013)

Neonatal Idiotypic Exposure Alters Subsequent Cytokine, Pathology, and Survival Patterns in Experimental Schistosoma mansoni Infections
por: Angela Montesano, M., et al.
Publicado: (1999)

Evaluation of Urine CCA Assays for Detection of Schistosoma mansoni Infection in Western Kenya
por: Shane, Hillary L., et al.
Publicado: (2011)

Fine-scale heterogeneity in Schistosoma mansoni force of infection measured through antibody response
por: Arnold, Benjamin F., et al.
Publicado: (2020)

Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration
por: Kura, Klodeta, et al.
Publicado: (2020)

Towards an Understanding of the Function of the Phytochelatin Synthase of Schistosoma mansoni
por: Rigouin, Coraline, et al.
Publicado: (2013)

Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission
por: Toor, Jaspreet, et al.
Publicado: (2019)

Change in children’s school behavior after mass administration of praziquantel for Schistosoma mansoni infection in endemic areas of western Kenya: A pilot study using the Behavioral Assessment System for Children (BASC-2)
por: Musuva, Rosemary, et al.
Publicado: (2017)

Effect of four rounds of annual school‐wide mass praziquantel treatment for schistosoma mansoni control on schistosome‐specific immune responses
por: Ndombi, E. M., et al.
Publicado: (2018)

Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni
por: Melman, Sandra D., et al.
Publicado: (2009)

Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages
por: Arndts, Kathrin, et al.
Publicado: (2021)

Comparison of the Impact of Different Mass Drug Administration Strategies on Infection with Schistosoma mansoni in Mwanza Region, Tanzania—A Cluster-Randomized Controlled Trial
por: Olsen, Annette, et al.
Publicado: (2018)

Schistogram changes after administration of antischistosomal drugs in mice at the early phase of Schistosoma mansoni infection
por: Vimieiro, Andréa Cássia Simões, et al.
Publicado: (2013)

Schistosoma mansoni Enhances Host Susceptibility to Mucosal but Not Intravenous Challenge by R5 Clade C SHIV
por: Siddappa, Nagadenahalli B., et al.
Publicado: (2011)

The cercarial glycocalyx of Schistosoma mansoni
Publicado: (1985)

CARBOHYDRATE METABOLISM OF SCHISTOSOMA MANSONI
por: Bueding, Ernest
Publicado: (1950)

Imatinib activity on Schistosoma mansoni
por: Katz, Naftale, et al.
Publicado: (2013)

Chlorination of Schistosoma mansoni cercariae
por: Braun, Laura, et al.
Publicado: (2020)

Association of the Gene Polymorphisms IFN-γ +874, IL-13 −1055 and IL-4 −590 with Patterns of Reinfection with Schistosoma mansoni
por: Gatlin, Michael R., et al.
Publicado: (2009)

Challenges to Making the Decision to Stop Mass Drug Administration for Onchocerciasis: Lessons Learned from Nigeria
por: Evans, Darin S.
Publicado: (2020)

Criteria for identification of Schistosoma mansoni eggs in faecal sediments prepared with the Helmintex method and stained by ninhydrin
por: de Souza, Renata Perotto, et al.
Publicado: (2019)

Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya
por: Abudho, Bernard O., et al.
Publicado: (2020)

Identification of Schistosoma mansoni microRNAs
por: Simões, Mariana C, et al.
Publicado: (2011)

The genome of the blood fluke Schistosoma mansoni
por: Berriman, Matthew, et al.
Publicado: (2009)

Characterization of the Phytochelatin Synthase of Schistosoma mansoni
por: Ray, Debalina, et al.
Publicado: (2011)

Acute paraplegia caused by Schistosoma mansoni
por: Al-Mendalawi, Mahmood D.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_eff2ccl3l45sle006i3q1e282s